nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Joint sprain—Dapsone—leprosy	0.0814	0.0814	CcSEcCtD
Vigabatrin—Retinitis—Thalidomide—leprosy	0.0798	0.0798	CcSEcCtD
Vigabatrin—Ligament sprain—Dapsone—leprosy	0.0647	0.0647	CcSEcCtD
Vigabatrin—Status epilepticus—Thalidomide—leprosy	0.0355	0.0355	CcSEcCtD
Vigabatrin—Suicide attempt—Dapsone—leprosy	0.0288	0.0288	CcSEcCtD
Vigabatrin—Hyporeflexia—Thalidomide—leprosy	0.0184	0.0184	CcSEcCtD
Vigabatrin—Suicide attempt—Thalidomide—leprosy	0.0147	0.0147	CcSEcCtD
Vigabatrin—Toothache—Thalidomide—leprosy	0.0138	0.0138	CcSEcCtD
Vigabatrin—Tooth disorder—Thalidomide—leprosy	0.0129	0.0129	CcSEcCtD
Vigabatrin—Menstrual disorder—Thalidomide—leprosy	0.0123	0.0123	CcSEcCtD
Vigabatrin—Nystagmus—Thalidomide—leprosy	0.0117	0.0117	CcSEcCtD
Vigabatrin—Psychotic disorder—Dapsone—leprosy	0.0116	0.0116	CcSEcCtD
Vigabatrin—Stupor—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Vigabatrin—Cholestasis—Thalidomide—leprosy	0.011	0.011	CcSEcCtD
Vigabatrin—Nasopharyngitis—Dapsone—leprosy	0.0106	0.0106	CcSEcCtD
Vigabatrin—Influenza—Dapsone—leprosy	0.0103	0.0103	CcSEcCtD
Vigabatrin—Endocrine disorder—Thalidomide—leprosy	0.0101	0.0101	CcSEcCtD
Vigabatrin—Acne—Thalidomide—leprosy	0.00994	0.00994	CcSEcCtD
Vigabatrin—Sensory loss—Thalidomide—leprosy	0.00966	0.00966	CcSEcCtD
Vigabatrin—Viral infection—Thalidomide—leprosy	0.00926	0.00926	CcSEcCtD
Vigabatrin—Arthropathy—Thalidomide—leprosy	0.0092	0.0092	CcSEcCtD
Vigabatrin—Thinking abnormal—Thalidomide—leprosy	0.00914	0.00914	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Dapsone—leprosy	0.00896	0.00896	CcSEcCtD
Vigabatrin—Dyskinesia—Thalidomide—leprosy	0.0089	0.0089	CcSEcCtD
Vigabatrin—Sinusitis—Dapsone—leprosy	0.00858	0.00858	CcSEcCtD
Vigabatrin—Gait disturbance—Thalidomide—leprosy	0.00857	0.00857	CcSEcCtD
Vigabatrin—Coordination abnormal—Thalidomide—leprosy	0.00852	0.00852	CcSEcCtD
Vigabatrin—Pulmonary embolism—Thalidomide—leprosy	0.00837	0.00837	CcSEcCtD
Vigabatrin—Depressed level of consciousness—Thalidomide—leprosy	0.00808	0.00808	CcSEcCtD
Vigabatrin—Candida infection—Thalidomide—leprosy	0.00799	0.00799	CcSEcCtD
Vigabatrin—Tinnitus—Dapsone—leprosy	0.00765	0.00765	CcSEcCtD
Vigabatrin—Oesophagitis—Thalidomide—leprosy	0.00764	0.00764	CcSEcCtD
Vigabatrin—Rash maculo-papular—Thalidomide—leprosy	0.0076	0.0076	CcSEcCtD
Vigabatrin—Hypertonia—Thalidomide—leprosy	0.00733	0.00733	CcSEcCtD
Vigabatrin—Hyperkinesia—Thalidomide—leprosy	0.0073	0.0073	CcSEcCtD
Vigabatrin—Mental disability—Thalidomide—leprosy	0.00726	0.00726	CcSEcCtD
Vigabatrin—Vascular purpura—Thalidomide—leprosy	0.00679	0.00679	CcSEcCtD
Vigabatrin—Deafness—Thalidomide—leprosy	0.00679	0.00679	CcSEcCtD
Vigabatrin—Vision blurred—Dapsone—leprosy	0.00673	0.00673	CcSEcCtD
Vigabatrin—Eye pain—Thalidomide—leprosy	0.00673	0.00673	CcSEcCtD
Vigabatrin—Increased appetite—Thalidomide—leprosy	0.00646	0.00646	CcSEcCtD
Vigabatrin—Amnesia—Thalidomide—leprosy	0.00646	0.00646	CcSEcCtD
Vigabatrin—Vertigo—Dapsone—leprosy	0.00642	0.00642	CcSEcCtD
Vigabatrin—Purpura—Thalidomide—leprosy	0.0063	0.0063	CcSEcCtD
Vigabatrin—Cough—Dapsone—leprosy	0.00623	0.00623	CcSEcCtD
Vigabatrin—Lethargy—Thalidomide—leprosy	0.0062	0.0062	CcSEcCtD
Vigabatrin—Diplopia—Thalidomide—leprosy	0.00607	0.00607	CcSEcCtD
Vigabatrin—Osteoarthritis—Thalidomide—leprosy	0.00607	0.00607	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00607	0.00607	CcSEcCtD
Vigabatrin—Pain in extremity—Thalidomide—leprosy	0.00607	0.00607	CcSEcCtD
Vigabatrin—Affect lability—Thalidomide—leprosy	0.00598	0.00598	CcSEcCtD
Vigabatrin—Psychotic disorder—Thalidomide—leprosy	0.00593	0.00593	CcSEcCtD
Vigabatrin—Face oedema—Thalidomide—leprosy	0.00586	0.00586	CcSEcCtD
Vigabatrin—Mood swings—Thalidomide—leprosy	0.00575	0.00575	CcSEcCtD
Vigabatrin—Ataxia—Thalidomide—leprosy	0.00571	0.00571	CcSEcCtD
Vigabatrin—Breast disorder—Thalidomide—leprosy	0.00549	0.00549	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00547	0.00547	CcSEcCtD
Vigabatrin—Abdominal distension—Thalidomide—leprosy	0.00528	0.00528	CcSEcCtD
Vigabatrin—Insomnia—Dapsone—leprosy	0.00527	0.00527	CcSEcCtD
Vigabatrin—Influenza—Thalidomide—leprosy	0.00525	0.00525	CcSEcCtD
Vigabatrin—Bronchitis—Thalidomide—leprosy	0.00505	0.00505	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Thalidomide—leprosy	0.00488	0.00488	CcSEcCtD
Vigabatrin—Erectile dysfunction—Thalidomide—leprosy	0.00483	0.00483	CcSEcCtD
Vigabatrin—Weight increased—Thalidomide—leprosy	0.00478	0.00478	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Dapsone—leprosy	0.00477	0.00477	CcSEcCtD
Vigabatrin—Pneumonia—Thalidomide—leprosy	0.00471	0.00471	CcSEcCtD
Vigabatrin—Infestation—Thalidomide—leprosy	0.00468	0.00468	CcSEcCtD
Vigabatrin—Infestation NOS—Thalidomide—leprosy	0.00468	0.00468	CcSEcCtD
Vigabatrin—Drowsiness—Thalidomide—leprosy	0.00468	0.00468	CcSEcCtD
Vigabatrin—Depression—Thalidomide—leprosy	0.00467	0.00467	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00464	0.00464	CcSEcCtD
Vigabatrin—Body temperature increased—Dapsone—leprosy	0.00461	0.00461	CcSEcCtD
Vigabatrin—Abdominal pain—Dapsone—leprosy	0.00461	0.00461	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Thalidomide—leprosy	0.00459	0.00459	CcSEcCtD
Vigabatrin—Conjunctivitis—Thalidomide—leprosy	0.00455	0.00455	CcSEcCtD
Vigabatrin—Sinusitis—Thalidomide—leprosy	0.00439	0.00439	CcSEcCtD
Vigabatrin—Hypoaesthesia—Thalidomide—leprosy	0.00418	0.00418	CcSEcCtD
Vigabatrin—Oedema peripheral—Thalidomide—leprosy	0.00414	0.00414	CcSEcCtD
Vigabatrin—Visual impairment—Thalidomide—leprosy	0.00405	0.00405	CcSEcCtD
Vigabatrin—Erythema multiforme—Thalidomide—leprosy	0.00397	0.00397	CcSEcCtD
Vigabatrin—Eye disorder—Thalidomide—leprosy	0.00393	0.00393	CcSEcCtD
Vigabatrin—Tinnitus—Thalidomide—leprosy	0.00392	0.00392	CcSEcCtD
Vigabatrin—Vomiting—Dapsone—leprosy	0.00371	0.00371	CcSEcCtD
Vigabatrin—Mental disorder—Thalidomide—leprosy	0.00368	0.00368	CcSEcCtD
Vigabatrin—Malnutrition—Thalidomide—leprosy	0.00366	0.00366	CcSEcCtD
Vigabatrin—Headache—Dapsone—leprosy	0.00365	0.00365	CcSEcCtD
Vigabatrin—Tension—Thalidomide—leprosy	0.00359	0.00359	CcSEcCtD
Vigabatrin—Nervousness—Thalidomide—leprosy	0.00355	0.00355	CcSEcCtD
Vigabatrin—Back pain—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Vigabatrin—Muscle spasms—Thalidomide—leprosy	0.00352	0.00352	CcSEcCtD
Vigabatrin—Nausea—Dapsone—leprosy	0.00346	0.00346	CcSEcCtD
Vigabatrin—Vision blurred—Thalidomide—leprosy	0.00345	0.00345	CcSEcCtD
Vigabatrin—Tremor—Thalidomide—leprosy	0.00343	0.00343	CcSEcCtD
Vigabatrin—Ill-defined disorder—Thalidomide—leprosy	0.00339	0.00339	CcSEcCtD
Vigabatrin—Anaemia—Thalidomide—leprosy	0.00338	0.00338	CcSEcCtD
Vigabatrin—Agitation—Thalidomide—leprosy	0.00336	0.00336	CcSEcCtD
Vigabatrin—Angioedema—Thalidomide—leprosy	0.00334	0.00334	CcSEcCtD
Vigabatrin—Malaise—Thalidomide—leprosy	0.0033	0.0033	CcSEcCtD
Vigabatrin—Vertigo—Thalidomide—leprosy	0.00329	0.00329	CcSEcCtD
Vigabatrin—Cough—Thalidomide—leprosy	0.00319	0.00319	CcSEcCtD
Vigabatrin—Convulsion—Thalidomide—leprosy	0.00317	0.00317	CcSEcCtD
Vigabatrin—Myalgia—Thalidomide—leprosy	0.00311	0.00311	CcSEcCtD
Vigabatrin—Arthralgia—Thalidomide—leprosy	0.00311	0.00311	CcSEcCtD
Vigabatrin—Chest pain—Thalidomide—leprosy	0.00311	0.00311	CcSEcCtD
Vigabatrin—Anxiety—Thalidomide—leprosy	0.0031	0.0031	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00309	0.00309	CcSEcCtD
Vigabatrin—Discomfort—Thalidomide—leprosy	0.00308	0.00308	CcSEcCtD
Vigabatrin—Confusional state—Thalidomide—leprosy	0.00301	0.00301	CcSEcCtD
Vigabatrin—Oedema—Thalidomide—leprosy	0.00298	0.00298	CcSEcCtD
Vigabatrin—Infection—Thalidomide—leprosy	0.00297	0.00297	CcSEcCtD
Vigabatrin—Nervous system disorder—Thalidomide—leprosy	0.00293	0.00293	CcSEcCtD
Vigabatrin—Skin disorder—Thalidomide—leprosy	0.0029	0.0029	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Thalidomide—leprosy	0.00272	0.00272	CcSEcCtD
Vigabatrin—Insomnia—Thalidomide—leprosy	0.0027	0.0027	CcSEcCtD
Vigabatrin—Paraesthesia—Thalidomide—leprosy	0.00268	0.00268	CcSEcCtD
Vigabatrin—Somnolence—Thalidomide—leprosy	0.00265	0.00265	CcSEcCtD
Vigabatrin—Dyspepsia—Thalidomide—leprosy	0.00263	0.00263	CcSEcCtD
Vigabatrin—Decreased appetite—Thalidomide—leprosy	0.00259	0.00259	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Thalidomide—leprosy	0.00258	0.00258	CcSEcCtD
Vigabatrin—Fatigue—Thalidomide—leprosy	0.00257	0.00257	CcSEcCtD
Vigabatrin—Pain—Thalidomide—leprosy	0.00255	0.00255	CcSEcCtD
Vigabatrin—Constipation—Thalidomide—leprosy	0.00255	0.00255	CcSEcCtD
Vigabatrin—Feeling abnormal—Thalidomide—leprosy	0.00246	0.00246	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Thalidomide—leprosy	0.00244	0.00244	CcSEcCtD
Vigabatrin—Urticaria—Thalidomide—leprosy	0.00237	0.00237	CcSEcCtD
Vigabatrin—Abdominal pain—Thalidomide—leprosy	0.00236	0.00236	CcSEcCtD
Vigabatrin—Body temperature increased—Thalidomide—leprosy	0.00236	0.00236	CcSEcCtD
Vigabatrin—Hypersensitivity—Thalidomide—leprosy	0.0022	0.0022	CcSEcCtD
Vigabatrin—Asthenia—Thalidomide—leprosy	0.00214	0.00214	CcSEcCtD
Vigabatrin—Pruritus—Thalidomide—leprosy	0.00211	0.00211	CcSEcCtD
Vigabatrin—Diarrhoea—Thalidomide—leprosy	0.00204	0.00204	CcSEcCtD
Vigabatrin—Dizziness—Thalidomide—leprosy	0.00197	0.00197	CcSEcCtD
Vigabatrin—Vomiting—Thalidomide—leprosy	0.0019	0.0019	CcSEcCtD
Vigabatrin—Rash—Thalidomide—leprosy	0.00188	0.00188	CcSEcCtD
Vigabatrin—Dermatitis—Thalidomide—leprosy	0.00188	0.00188	CcSEcCtD
Vigabatrin—Headache—Thalidomide—leprosy	0.00187	0.00187	CcSEcCtD
Vigabatrin—Nausea—Thalidomide—leprosy	0.00177	0.00177	CcSEcCtD
